COMPANY PROFILE

Motif Neurotech

Explore full profile

Minimally invasive electronic solutions for mental health

Houston, United StatesFounded 2022Health Tech & Medtech

Valuation $100–250M Last recorded · 2024

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Motif Neurotech

Motif Neurotech operates in the cutting-edge field of neurotechnology, specializing in the development of minimally invasive neural implants. These implants are wirelessly powered via magnetic fields from an external wearable transmitter, ensuring seamless operation and functionality. The company primarily serves the medical sector, focusing on both animal research and human applications. Their business model revolves around the design, development, and commercialization of these advanced neurotech devices. Revenue is generated through the sale of these devices, as well as through partnerships and collaborations with medical institutions and research organizations. Motif Neurotech employs a full-stack engineering approach, from initial PCB design and layout to embedded firmware development, ensuring that all products meet stringent regulatory, safety, and user requirements. Additionally, the company places a strong emphasis on quality management, utilizing an Electronic Quality Management System (eQMS) to maintain high standards across all operations. This system is crucial for transitioning their research devices into market-ready products. The company is poised for growth, with plans to expand its team of quality engineers and technical writers to support its mission of advancing neurotechnology.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2022
Headquarters: Houston, United States
Employees: 31
Open positions: 1
Dealroom signal: 65.7/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, medical implants, Mental Health, Neuromodulation and Neurostimulation, Hard Tech, DT and LS, science-based
Technology: Deep Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
GRANT✓Other financing	Jan 2025	$0	—	ARIA	↗
EARLY VC✓Equity / VC	Jan 2024	$19M	$75M	Undisclosed	↗

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Motif Neurotech website traffic

Latest recorded traffic for Motif Neurotech is 5K monthly website visits, down 5.7% over the last three months. Motif Neurotech's team declined 3.1% over the past year.

Latest monthly visits5K 3-month web change-5.7% 1-year team growth-3.1%

Monthly website visitsApr 2023–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Director of Clinical Science and Applied ResearchHouston, Texas, United States, Northern America, Americas · Other · Jul 24, 2026

1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
AVAvivomedDeveloping and commercializing next generation neuromodulaton technology platforms to treat patients suffering from chronic diseases	Minneapolis, United States	Operational	18	$32M	$128M
MMMagnus MedicalA privately held medical device company developing a novel, rapid-acting brain stimulation technology designed to treat people suffering from major depressive disorder (MDD) who have not responded to existing treatments	Burlingame, United States	Operational
HYHylomorphHylomorph is an innovative Medtech company engineering biomaterials to optimize the interface between implantable medical devices and tissues	Zurich, Switzerland	Operational
NENeuroliefDevelops proprietary digital theraputics neuromodulation technology to treat neurological and neuropsychiatric disorders such as migraine and depression	Netanya, Israel	Operational
BMBlueWind MedicalEvelops and markets an innovative wireless neuro-stimulation device for the treatment of peripheral neuropathic pain	Herzliya, Israel	Operational
NENeuroPaceDeveloping and marketing implantable devices for the treatment of neurological disorders	Mountain View, United States	Operational
VTValencia TechnologiesAlencia Technologies is a neuromodulation company transforming the standard of care for bladder dysfunction	Santa Clarita, United States	Acquired
WNWave NeuroscienceInnovative neuromodulation technologies enhancing brain function without pharmaceuticals or invasive procedures	Newport Beach, United States	Operational